Comparison of Time Taken to Diagnose Intraoperative Coagulopathies Using VET and SCL
Launched by KONKUK UNIVERSITY MEDICAL CENTER · Oct 9, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to compare two different ways of diagnosing bleeding problems during surgery, specifically focusing on how quickly each method works. The study will use a new test called point-of-care (POC) viscoelastic tests, which can give results right in the operating room, and compare it to standard laboratory tests that take longer. The goal is to find out which method helps doctors identify bleeding issues faster during surgeries that have a higher risk of significant bleeding.
To participate in this trial, patients will need to be scheduled for certain types of elective surgeries, like heart surgery, joint replacements, or surgeries for cancer, and must be at risk for bleeding. They also need to be able to provide written consent to take part. If you join the study, you can expect to be monitored closely during your surgery to see how quickly the tests can diagnose any bleeding problems. It’s important to note that pregnant individuals and those who decide not to participate or whose surgery is stopped for any reason cannot be included in the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients who will undergo elective surgery with a high risk of moderate to severe amount of intraoperative bleeding or coagulopathy (e.g., cardiac surgery, joint replacement, spine surgery, hepatectomy, radical prostatectomy)
- • patients who provide written informed consent
- • patients who may warrant the intraoperative use of POC viscoelastic test or SCL test
- Exclusion Criteria:
- • pregnancy
- • withdrawal of consent
- • termination of surgery without performing either POC viscoelastic test or SCL tests
- • when the study conductor deems it inappropriate to proceed with the protocol with the patient
About Konkuk University Medical Center
Konkuk University Medical Center is a leading healthcare institution located in Seoul, South Korea, recognized for its commitment to advancing medical research and improving patient care. As a clinical trial sponsor, the center leverages its state-of-the-art facilities and multidisciplinary expertise to conduct innovative research that addresses critical health challenges. With a focus on collaboration and ethical standards, Konkuk University Medical Center aims to contribute significantly to the development of new treatments and therapies, enhancing the overall quality of healthcare both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Tae-yop Kim
Principal Investigator
Konkuk University Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported